In May 2022, Precision BioLogic introduced its CRYOcheck Chromogenic Factor IX assay for monitoring hemophilia B in the EU, UK, Australia, Canada, and New Zealand after receiving regulatory approvals. This assay features a wide testing range, user-friendly design, and compatibility with automated analyzers, significantly improving hemophilia testing capabilities in these regions
Frequently Asked Questions
The market is segmented based on Segmentation, By Product Type (Systems and Instruments and Consumables and Accessories), Application (Clinical Applications and Research Applications), End-use (Hospital, Diagnostic Centers, and Research and Academic Institutes) – Industry Trends and Forecast to 2031
.
The Global Platelet Aggregation Devices Market size was valued at USD 0.00 USD Million in 2023.
The Global Platelet Aggregation Devices Market is projected to grow at a CAGR of 20.65% during the forecast period of 2024 to 2031.
The major players operating in the market include Siemens, Helena Laboratories Corporation, Bio Data Corporation, Drucker Diagnostics, Haemonetics Corporation, WerfenLife S.A., Matis Medical , Laboratory Corporation of America Holdings, Pathway Diagnostics Limited, F. Hoffman-La Roche Ltd, Sysmex Corporation, The Instrumentation Laboratory, Sienco , SENTINEL CH. SpA, AggreDYNE.com, Accriva Diagnostics Holdings , Tem Group, TERUMO BCT , Fresenius SE & Co. KGaA, Thermo Fisher Scientific .
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, Rest of South America.
